Related Experiment Videos
Summary
Motor Neurone Disease (MND) significantly impacts patients, with average survival around 22-28 months. Early interventions like physiotherapy and supportive communication are crucial for managing progressive disabilities and improving quality of life.
Area of Science:
- Neurology
- Clinical Medicine
Background:
- Motor Neurone Disease (MND) is a progressive neurodegenerative disorder.
- Understanding the disease course and patient management is crucial for care.
Purpose of the Study:
- To describe the clinical course of Motor Neurone Disease (MND) in 22 patients.
- To analyze the extent and duration of disabilities.
- To evaluate patient survival and management challenges.
Main Methods:
- Retrospective analysis of 22 patients with Motor Neurone Disease (MND).
- Detailed observation of disease progression, including disabilities in breathing, swallowing, mobility, and communication.
- Documentation of hospital stay duration and overall disease duration.
Main Results:
- Average hospital stay in the terminal phase was 6.6 months for men and 4.7 months for women.
- Total disease duration ranged from 11 to 45 months (average 28.7 months for men, 22.2 months for women).
- No significant difference in average survival was observed between different initial forms of MND (bulbar, cervical, lumbar, mixed).
- Pain affected one-third of patients.
- Physiotherapy with passive movements and supportive communication (encouraging expression through art, writing) were found beneficial.
Conclusions:
- Motor Neurone Disease (MND) presents a progressive decline affecting multiple functions.
- Management requires a multidisciplinary approach, including physiotherapy, nutritional support (gastrostomy feeding), and psychosocial support.
- Assisted respiration is a significant consideration in advanced stages of MND.